Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2017, Page 2

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2017-04-27: Form 6-K; Period of report 2017-04-27; Description COMPANIES ACT 2006 S430 (2B) DISCLOSURE; Document a6103d.htm.
  • 2017-04-26: Form 6-K; Period of report 2017-04-26; Description INDENTURE 2004 - CHANGE OF TRUSTEE; Document a4650d.htm.
  • 2017-04-26: Form 6-K; Period of report 2017-04-26; Description 1ST QUARTER RESULTS; Document a4004d.htm.
  • 2017-04-25: Form 6-K; Period of report 2017-04-25; Description DIRECTOR/PDMR SHAREHOLDING; Document a3217d.htm.
FiledFormPeriod of reportDescriptionDocument
2017-04-276-K2017-04-27COMPANIES ACT 2006 S430 (2B) DISCLOSUREa6103d.htm
2017-04-266-K2017-04-26INDENTURE 2004 - CHANGE OF TRUSTEEa4650d.htm
2017-04-266-K2017-04-261ST QUARTER RESULTSa4004d.htm
2017-04-256-K2017-04-25DIRECTOR/PDMR SHAREHOLDINGa3217d.htm
2017-04-256-K2017-04-25DIRECTOR/PDMR SHAREHOLDINGa2799d.htm
2017-04-246-K/A2017-04-24DIRECTOR/PDMR SHAREHOLDINGa1730d.htm
2017-04-216-K2017-04-21DIRECTOR/PDMR SHAREHOLDINGa0297d.htm
2017-04-216-K2017-04-21DIRECTOR/PDMR SHAREHOLDINGa0195d.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7871c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7757c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7395c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7725c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7748c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7713c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7393c.htm
2017-04-196-K2017-04-19DIRECTOR/PDMR SHAREHOLDINGa7387c.htm
2017-04-186-K2017-04-18DIRECTOR/PDMR SHAREHOLDINGa6350c.htm
2017-04-186-K2017-04-18GSK VACCINE SUBMISSION FOR SHINGLES IN JAPANa5712c.htm
2017-04-116-K2017-04-11DIRECTOR/PDMR SHAREHOLDINGa2510c.htm
2017-04-116-K2017-04-11CHANGE TO FINANCIAL REPORTING FRAMEWORKa2127c.htm
2017-04-036-K2017-04-03TOTAL VOTING RIGHTSa3779b.htm
2017-03-316-K2017-03-31PHASE 3 STUDY START OF MEPOLIZUMAB IN SEVERE HESa1776b.htm
2017-03-306-K2017-03-30NOTICE OF AGMa0465b.htm
2017-03-236-K2017-03-23DIRECTOR/PDMR SHAREHOLDINGa3912a.htm
2017-03-216-K2017-03-21DIRECTOR/PDMR SHAREHOLDINGa0895a.htm
2017-03-206-K2017-03-20GSK 2016 FORM 20Fa8752z.htm
2017-03-166-K2017-03-16DIRECTOR/PDMR SHAREHOLDINGa7377z.htm
2017-03-156-K2017-03-15DIRECTOR/PDMR SHAREHOLDINGa6065z.htm
2017-03-146-K2017-03-14PUBLICATION OF 2016 ANNUAL FINANCIAL REPORTa4350z.htm
2017-03-106-K2017-03-10DIRECTOR/PDMR SHAREHOLDINGa1950z.htm
2017-03-086-K2017-03-08DIRECTOR/PDMR SHAREHOLDINGa9139y.htm
2017-03-066-K2017-03-06DIRECTOR/PDMR SHAREHOLDINGa6633y.htm
2017-03-066-K2017-03-06GSKS MUSCA STUDY RESULTS ON NUCALA (MEPOLIZUMAB)a6478y.htm
2017-03-016-K2017-03-01TOTAL VOTING RIGHTSa2064y.htm
2017-02-236-K2017-02-23DIRECTOR/PDMR SHAREHOLDINGa7177x.htm
2017-02-236-K2017-02-23DIRECTOR/PDMR SHAREHOLDINGa7168x.htm
2017-02-236-K2017-02-23POSITIVE RESULTS FOR RELVAR ELLIPTA LUNG STUDYa6697x.htm
2017-02-226-K2017-02-22DIRECTOR/PDMR SHAREHOLDINGa5769x.htm
2017-02-216-K2017-02-21DIRECTOR/PDMR SHAREHOLDINGa4792x4.htm
2017-02-216-K2017-02-21DIRECTOR/PDMR SHAREHOLDINGa3595x.htm
2017-02-216-K2017-02-21DIRECTOR/PDMR SHAREHOLDINGa3323x.htm
2017-02-176-K2017-02-17DIRECTOR/PDMR SHAREHOLDINGa2296x.htm
2017-02-176-K2017-02-17DIRECTOR/PDMR SHAREHOLDINGa2294x.htm
2017-02-176-K2017-02-17DIRECTOR/PDMR SHAREHOLDINGa2290x.htm
2017-02-156-K2017-02-15DIRECTOR/PDMR SHAREHOLDINGa0119x.htm
2017-02-146-K2017-02-14DIRECTOR/PDMR SHAREHOLDINGa8614w.htm
2017-02-146-K2017-02-14DIRECTOR/PDMR SHAREHOLDINGa8273w.htm
2017-02-146-K2017-02-14VIIV PHASE III RESULTS DOLUTEGRAVIR & RILPIVIRINEa7794w.htm
2017-02-136-K2017-02-13DIRECTOR/PDMR SHAREHOLDINGa7693w.htm
2017-02-106-K2017-02-10DIRECTOR/PDMR SHAREHOLDINGa6544w.htm
2017-02-106-K2017-02-10DIRECTOR/PDMR SHAREHOLDINGa6141w.htm
2017-02-106-K2017-02-10BLOCKLISTING APPLICATIONa5923w.htm
2017-02-096-K2017-02-09DIRECTOR/PDMR SHAREHOLDINGa5450w.htm
2017-02-096-K2017-02-09DIRECTOR/PDMR SHAREHOLDINGa4771w.htm
2017-02-086-K2017-02-08DIRECTOR/PDMR SHAREHOLDINGa3876w000.htm
2017-02-086-K2017-02-08FINAL RESULTSa3451w.htm
2017-02-016-K2017-02-01TOTAL VOTING RIGHTSa7501v.htm
2017-01-256-K2017-01-25DIRECTOR/PDMR SHAREHOLDINGa1319v.htm
2017-01-246-K2017-01-24DIRECTOR/PDMR SHAREHOLDINGa0101v.htm
2017-01-236-K2017-01-23DIRECTOR/PDMR SHAREHOLDINGa8857u.htm
2017-01-206-K2017-01-20DIRECTOR/PDMR SHAREHOLDINGa7635u.htm
2017-01-196-K2017-01-19CORPORATE EXECUTIVE TEAM CHANGESa5839u.htm
2017-01-196-K2017-01-19CORPORATE EXECUTIVE TEAM CHANGESa5836u.htm
2017-01-176-K2017-01-17DIRECTOR/PDMR SHAREHOLDINGa2974u.htm
2017-01-176-K2017-01-17DIRECTOR/PDMR SHAREHOLDINGa2966u.htm
2017-01-176-K2017-01-17DIRECTOR/PDMR SHAREHOLDINGa2835u.htm
2017-01-176-K2017-01-16DIRECTOR/PDMR SHAREHOLDINGa2922u.htm
2017-01-176-K2017-01-17DIRECTOR/PDMR SHAREHOLDINGa2841u.htm
2017-01-176-K2017-01-17DIRECTOR/PDMR SHAREHOLDINGa2911u.htm
2017-01-176-K2017-01-17DIRECTOR/PDMR SHAREHOLDINGa2896u.htm
2017-01-136-K2017-01-13DIRECTOR/PDMR SHAREHOLDINGa1732u.htm
2017-01-136-K2017-01-13DIRECTOR/PDMR SHAREHOLDINGedgar.htm
2017-01-136-K2017-01-13DIRECTOR/PDMR SHAREHOLDINGa1641u.htm
2017-01-126-K2017-01-12DIRECTOR/PDMR SHAREHOLDINGa0781u.htm
2017-01-106-K2017-01-10DIRECTOR/PDMR SHAREHOLDINGa8361t.htm
2017-01-036-K2017-01-03TOTAL VOTING RIGHTSa1878t.htm